Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 8, 2020
Reply to L.H. Einhorn et al
Deaglan McHugh, George J Bosl, Samuel A Funt, et al.
Clinical Genitourinary Cancer
|
June 5, 2021
A Phase II, Nonrandomized Open Trial Assessing Pain Efficacy with Radium-223 in Symptomatic Metastatic Castration-resistant Prostate Cancer
Deaglan McHugh, Scott Tagawa, Natalie Moryl, et al.
Investigational New Drugs
|
February 7, 2019
A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer
Deaglan McHugh, Mario Eisenberger, Elisabeth I Heath, et al.
Annals of Surgery
|
January 25, 2020
Outcomes After Multidisciplinary Management of Primary Mediastinal Germ Cell Tumors
Raul Caso, Gregory D Jones, Manjit S Bains, et al.
European Urology Oncology
|
November 9, 2023
A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer
Ritesh R Kotecha, Sahil D Doshi, Andrea Knezevic, et al.
JCO Precision Oncology
|
March 18, 2026
Genomic Features and Response to Poly(ADP-ribose) Polymerase Inhibition in Metastatic Castration-Resistant Prostate Cancer
Jeffery C W Chang, Subhiksha Nandakumar, Konrad H Stopsack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2022
Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial
Samuel A Funt, Michael Lattanzi, Karissa Whiting, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 20, 2025
Accelerating Drug Development in Hormone-Naïve Prostate Cancer Through Multi-Modal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial
Deaglan McHugh, Matthew Dallos, Min Yuen Teo, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 8, 2020
Reply to L.H. Einhorn et al
Deaglan McHugh, George J Bosl, Samuel A Funt, et al.
Clinical Genitourinary Cancer
|
June 5, 2021
A Phase II, Nonrandomized Open Trial Assessing Pain Efficacy with Radium-223 in Symptomatic Metastatic Castration-resistant Prostate Cancer
Deaglan McHugh, Scott Tagawa, Natalie Moryl, et al.
Investigational New Drugs
|
February 7, 2019
A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer
Deaglan McHugh, Mario Eisenberger, Elisabeth I Heath, et al.
Annals of Surgery
|
January 25, 2020
Outcomes After Multidisciplinary Management of Primary Mediastinal Germ Cell Tumors
Raul Caso, Gregory D Jones, Manjit S Bains, et al.
European Urology Oncology
|
November 9, 2023
A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer
Ritesh R Kotecha, Sahil D Doshi, Andrea Knezevic, et al.
JCO Precision Oncology
|
March 18, 2026
Genomic Features and Response to Poly(ADP-ribose) Polymerase Inhibition in Metastatic Castration-Resistant Prostate Cancer
Jeffery C W Chang, Subhiksha Nandakumar, Konrad H Stopsack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2022
Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial
Samuel A Funt, Michael Lattanzi, Karissa Whiting, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 20, 2025
Accelerating Drug Development in Hormone-Naïve Prostate Cancer Through Multi-Modal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial
Deaglan McHugh, Matthew Dallos, Min Yuen Teo, et al.
Page
of 1